FAUSTINI, Gaia
 Distribuzione geografica
Continente #
NA - Nord America 2.091
EU - Europa 1.643
AS - Asia 1.206
SA - Sud America 202
AF - Africa 28
OC - Oceania 4
Totale 5.174
Nazione #
US - Stati Uniti d'America 2.053
PL - Polonia 673
SG - Singapore 426
CN - Cina 373
IT - Italia 273
BR - Brasile 169
UA - Ucraina 164
DE - Germania 143
HK - Hong Kong 124
FI - Finlandia 95
VN - Vietnam 92
GB - Regno Unito 69
FR - Francia 46
RU - Federazione Russa 46
TR - Turchia 46
IE - Irlanda 40
IN - India 34
ID - Indonesia 20
KR - Corea 19
SE - Svezia 19
BD - Bangladesh 18
CA - Canada 18
MX - Messico 17
CZ - Repubblica Ceca 16
AR - Argentina 14
NL - Olanda 14
ZA - Sudafrica 10
AT - Austria 9
BE - Belgio 8
ES - Italia 7
IL - Israele 7
EG - Egitto 6
IQ - Iraq 6
JP - Giappone 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
MA - Marocco 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CO - Colombia 4
IR - Iran 4
KE - Kenya 4
LT - Lituania 4
PK - Pakistan 4
AU - Australia 3
CH - Svizzera 3
VE - Venezuela 3
AM - Armenia 2
BO - Bolivia 2
EE - Estonia 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.174
Città #
Warsaw 671
Singapore 210
Fairfield 201
Ashburn 193
Jacksonville 128
Hong Kong 123
Chandler 120
Woodbridge 101
Beijing 100
Brescia 96
Cambridge 86
Seattle 84
Dearborn 77
Houston 76
Helsinki 74
Princeton 72
New York 71
Wilmington 68
Ann Arbor 61
Dallas 41
Los Angeles 41
Dublin 40
Munich 38
Dong Ket 36
Istanbul 36
Nanjing 34
Milan 29
San Francisco 22
Ho Chi Minh City 20
Boardman 19
Moscow 19
Shanghai 19
Buffalo 18
Chicago 18
Jakarta 17
Jinan 17
São Paulo 17
Des Moines 16
The Dalles 16
Redondo Beach 15
Pune 13
San Diego 13
San Giuliano Milanese 13
Shenyang 13
Tucson 13
Denver 12
Santa Clara 12
Tianjin 12
Hebei 11
Lappeenranta 11
Nuremberg 11
Brno 10
Toronto 10
Changsha 9
London 9
Rome 8
Turku 8
Brussels 7
Cattolica 7
Hanoi 7
Poplar 7
San Donà Di Piave 7
Stockholm 7
Boston 6
Brooklyn 6
Council Bluffs 6
Guangzhou 6
Hangzhou 6
Lanzhou 6
Manchester 6
Nanchang 6
Pavia 6
Phoenix 6
Rio de Janeiro 6
Romola 6
Taizhou 6
Tokyo 6
Ankara 5
Cagliari 5
Cairo 5
Jiaxing 5
Johannesburg 5
Kunming 5
Oxford 5
Providence 5
San Cesareo 5
Zhengzhou 5
Baku 4
Charlotte 4
Dhaka 4
Hefei 4
Mexico City 4
Nairobi 4
Napoli 4
New Delhi 4
Ningbo 4
Olomouc 4
Paris 4
Salt Lake City 4
Salò 4
Totale 3.556
Nome #
Anionic liposomes for siRNA delivery to primary neuronal cells: evaluation of Alpha synuclein knockdown efficacy 320
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 288
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 248
Living in promiscuity: The multiple partners of alpha-synuclein at the synapse in physiology and pathology 204
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 200
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 192
Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells 188
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 183
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 183
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 154
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy 151
Synapsin III alterations in Parkinson's disease 147
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 135
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 126
Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET-Based Assay of Synapsin III Binding 124
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 119
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 116
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 115
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 110
Synapsin III knock-out reduces AAV-alpha-synuclein overexpression-related neuropathology in the nigrostriatal system 109
Synapsin III and Alpha-Synuclein cooperation in the onset of synaptic pathology in Parkinson’s Disease 109
Parkinson's disease: from synaptic loss to connectome dysfunction 106
Exploring LRRK2-dependent clearance of α-synuclein pffs in glial cells via clusterin 106
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 105
Study of alpha-synuclein fibrillation: State of the art and expectations 102
The good and bad of therapeutic strategies that directly target α-synuclein 102
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 96
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease 94
. Alpha-synuclein is a crucial mediator of mitochondrial fusion and functions 94
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and synaptic protein’s redistribution 82
Alpha-synuclein absence affected mitochondrial fusion and functions 82
Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction 81
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease 81
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy? 73
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice 70
Validation of synapsin III as a therapeutic target for Parkinson’s disease in the AAV-mediated alpha-synuclein mouse model 65
The association between α-synuclein and α-tubulin in brain synapses 65
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype 64
Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates 59
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease 52
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease 49
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease 49
A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage 49
Lewy pathology formation in patient-derived GBA1 Parkinson's disease midbrain organoids 21
Experimental Ischemic Stroke-Induced Alpha-Synuclein Pathology Enhances Endothelial Inflammatory Response and Impairs Angiogenesis 7
Totale 5.275
Categoria #
all - tutte 24.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021450 0 0 0 0 0 59 26 76 68 92 65 64
2021/2022339 29 43 23 12 4 28 13 28 19 25 41 74
2022/2023376 50 1 10 30 35 93 3 38 64 10 18 24
2023/2024422 35 8 39 37 20 80 17 16 73 10 14 73
2024/2025853 5 13 19 107 98 64 96 52 92 45 149 113
2025/20261.073 179 214 136 288 214 42 0 0 0 0 0 0
Totale 5.275